Czech Republic Pharmaceuticals and Healthcare Report Q3 2013
Reportstack, provider of premium market research reports announces the addition of Czech Republic Pharmaceuticals and Healthcare Report Q3 2013 market report to its offering
The Ministry of Health's decision to reimburse the state insurer more for taking on expensive
patients suggests state favouritism, but given the VzP's longer list of high-risk patients, it is understandable.
The fact that private insurers have not diversified their pools of patients has meant that the most demanding
patients have ended up with the VzP,...
View full press release